Please provide your email address to receive an email when new articles are posted on . Cross-linking is a resource-intensive procedure. Designating cross-linking “champions” will help improve and ...
An epithelium-off corneal cross-linking treatment has been approved in the U.S. for nearly a decade.During that time, we have ...
Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
To provide an insight into trends in corneal cross-linking (CXL) practice in the UK, including criteria for progression of corneal ectasia, identification of patients for CXL, the CXL procedure itself ...
Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus, a Sight-Threatening Rare Disease Glaukos Corporation ...
Credit: Glaukos. The topical drug therapy uses epithelium-on cross-linking to reduce corneal steepness in adults. Unlike traditional cross-linking procedures, this treatment does not require removal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results